BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 9930351)

  • 1. The selectable marker neo gene down-regulates gene expression from retroviral vectors containing an internal ribosome entry site.
    Byun J; Kim JM; Robbins PD; Kim S
    Gene Ther; 1998 Oct; 5(10):1441-4. PubMed ID: 9930351
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of the relative level of gene expression from different retroviral vectors used for gene therapy.
    Byun J; Kim SH; Kim JM; Yu SS; Robbins PD; Yim J; Kim S
    Gene Ther; 1996 Sep; 3(9):780-8. PubMed ID: 8875226
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generation of a conditionally neo(r)-containing retroviral producer cell line: effects of neo(r) on retroviral titer and transgene expression.
    Wildner O; Candotti F; Krecko EG; Xanthopoulos KG; Ramsey WJ; Blaese RM
    Gene Ther; 1998 May; 5(5):684-91. PubMed ID: 9797874
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generation of mammalian cells stably expressing multiple genes at predetermined levels.
    Liu X; Constantinescu SN; Sun Y; Bogan JS; Hirsch D; Weinberg RA; Lodish HF
    Anal Biochem; 2000 Apr; 280(1):20-8. PubMed ID: 10805516
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of bicistronic retroviral vectors containing internal ribosome entry sites (IRES) using expression of human interleukin-12 (IL-12) as a readout.
    Harries M; Phillipps N; Anderson R; Prentice G; Collins M
    J Gene Med; 2000; 2(4):243-9. PubMed ID: 10953915
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A convenient method for positive selection of retroviral producing cells generating vectors devoid of selectable markers.
    Xu L; Tsuji K; Mostowski H; Otsu M; Candotti F; Rosenberg AS
    J Virol Methods; 2004 Jun; 118(1):61-7. PubMed ID: 15158069
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of bicistronic retroviral vectors encoding the LacZ gene together with a gene of interest: a method to select producer cells and follow transduced target cells.
    Staal FJ; Bakker AQ; Verkuijlen M; van Oort E; Spits H
    Cancer Gene Ther; 1996; 3(5):345-51. PubMed ID: 8894254
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Construction of a high efficiency retroviral vector for gene therapy of Hunter's syndrome.
    Hong Y; Yu SS; Kim JM; Lee K; Na YS; Whitley CB; Sugimoto Y; Kim S
    J Gene Med; 2003 Jan; 5(1):18-29. PubMed ID: 12516048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Construction and Expression of Polycistronic Retroviral Vector Carrying Genes of TNF-alpha, IL-2 and NeoR.
    Lai GH; Tang ZY; Chen SS
    Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 1998; 30(2):159-163. PubMed ID: 12174276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An improved method for generating retroviral producer clones for vectors lacking a selectable marker gene.
    Persons DA; Mehaffey MG; Kaleko M; Nienhuis AW; Vanin EF
    Blood Cells Mol Dis; 1998 Jun; 24(2):167-82. PubMed ID: 9642098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In situ generation of pseudotyped retroviral progeny by adenovirus-mediated transduction of tumor cells enhances the killing effect of HSV-tk suicide gene therapy in vitro and in vivo.
    Okada T; Caplen NJ; Ramsey WJ; Onodera M; Shimazaki K; Nomoto T; Ajalli R; Wildner O; Morris J; Kume A; Hamada H; Blaese RM; Ozawa K
    J Gene Med; 2004 Mar; 6(3):288-99. PubMed ID: 15026990
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Construction and application of retroviral vector system useful for high-efficiency transfection into human T cells].
    Zhang RP; Yun L; Peng L; Lu B; Zhou Q; Wang H; Guo YJ
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2006 Jul; 22(4):420-2, 426. PubMed ID: 16805997
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Efficient expression of multidrug resistance gene mdr1 in retroviral vector under control of an internal ribosome entry site].
    Fu J; Chen Z; Wang W
    Zhonghua Xue Ye Xue Za Zhi; 1998 Dec; 19(12):619-22. PubMed ID: 11263327
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Versatile retroviral vectors for potential use in gene therapy.
    Hawley RG; Lieu FH; Fong AZ; Hawley TS
    Gene Ther; 1994 Mar; 1(2):136-8. PubMed ID: 7584069
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of a new bicistronic retroviral vector with strong IRES activity.
    Martin P; Albagli O; Poggi MC; Boulukos KE; Pognonec P
    BMC Biotechnol; 2006 Jan; 6():4. PubMed ID: 16409632
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retrovirus mediated in vivo gene transfer to synovium in bacterial cell wall-induced arthritis in rats.
    Makarov SS; Olsen JC; Johnston WN; Schwab JH; Anderle SK; Brown RR; Haskill JS
    Gene Ther; 1995 Aug; 2(6):424-8. PubMed ID: 7584118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characteristics of ovarian cancer cells transduced by the bicistronic retroviral vector containing GM-CSF and HSV-TK genes.
    Guan J; Ma L; Wei L
    Chin Med J (Engl); 2001 Feb; 114(2):147-51. PubMed ID: 11780195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use and comparison of different internal ribosomal entry sites (IRES) in tricistronic retroviral vectors.
    Douin V; Bornes S; Creancier L; Rochaix P; Favre G; Prats AC; Couderc B
    BMC Biotechnol; 2004 Jul; 4():16. PubMed ID: 15279677
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors affecting the performance of different long terminal repeats in the retroviral vector.
    Kim S; Lee K; Kim MD; Kang S; Joo CW; Kim JM; Kim SH; Yu SS; Kim S
    Biochem Biophys Res Commun; 2006 May; 343(4):1017-22. PubMed ID: 16574062
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retroviral bicistronic vectors.
    Pfützner W
    Drug News Perspect; 2008 Nov; 21(9):473-80. PubMed ID: 19180265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.